Beta(2)-agonists: déjà vu all over again: the second-generation controversy.
Bernstein
I Leonard
IL
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D016907:Adverse Drug Reaction Reporting Systems; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D002423:Cause of Death; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans
D000318:Adrenergic beta-Agonists